(Q44967650)

7 December 2017

title

Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus (English)

1 reference

silent myocardial ischemia

7 December 2017

1 reference

1 reference

Savas Guzel

1

1 reference

7 December 2017

Arzu Seven

2

1 reference

7 December 2017

Ali Kocaoglu

3

1 reference

7 December 2017

Banu Ilk

4

1 reference

7 December 2017

Eda C Guzel

5

1 reference

7 December 2017

Gamze V Saracoglu

6

1 reference

7 December 2017

Aslan Celebi

7

1 reference

7 December 2017

language of work or name

English

0 references

publication date

11 April 2012

1 reference

Diabetes and Vascular Disease Research

7 December 2017

published in

1 reference

7 December 2017

volume

10

1 reference

7 December 2017

issue

1

1 reference

7 December 2017

page(s)

25-31

1 reference

Proatherogenic pathways leading to vascular calcification

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Prevalence of asymptomatic myocardial ischaemia in diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Osteoprotegerin, vascular calcification and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Impact of ENPP1 and MMP3 gene polymorphisms on aortic calcification in patients with type 2 diabetes in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Silent coronary artery disease in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

The relationship between coronary artery calcification score, plasma osteoprotegerin level and arterial stiffness in asymptomatic type 2 DM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Acute hyperinsulinemia decreases plasma osteoprotegerin with diminished effect in type 2 diabetes and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Plasma leptin levels and coronary artery calcification in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Resistin and obesity-associated insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

The prevalence of silent myocardial ischaemia in patients with white-coat hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Silent myocardial ischemia and microalbuminuria in asymptomatic subjects with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Plasma Leptin Levels Are Associated with Coronary Atherosclerosis in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

Determinants of Progression of Coronary Artery Calcification in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112440815

21 January 2018

Identifiers

DOI

10.1177/1479164112440815

1 reference

7 December 2017

1 reference